These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Lack of cross-protection against diarrhea due to Vibrio cholerae O139 (Bengal strain) after oral immunization of rabbits with V. cholerae O1 vaccine strain CVD103-HgR. Albert MJ; Alam K; Ansaruzzaman M; Qadri F; Sack RB J Infect Dis; 1994 Jan; 169(1):230-1. PubMed ID: 8277193 [No Abstract] [Full Text] [Related]
30. Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1. Kenner JR; Coster TS; Taylor DN; Trofa AF; Barrera-Oro M; Hyman T; Adams JM; Beattie DT; Killeen KP; Spriggs DR J Infect Dis; 1995 Oct; 172(4):1126-9. PubMed ID: 7561195 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of a live oral cholera vaccine in human volunteers. Woodward WE; Gilman RH; Hornick RB; Libonati JP; Cash RA Dev Biol Stand; 1976; 33():108-12. PubMed ID: 782960 [TBL] [Abstract][Full Text] [Related]
32. Successful comeback of the single-dose live oral cholera vaccine CVD 103-HgR. Herzog C Travel Med Infect Dis; 2016; 14(4):373-7. PubMed ID: 27425792 [TBL] [Abstract][Full Text] [Related]
33. Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108. Liang W; Wang S; Yu F; Zhang L; Qi G; Liu Y; Gao S; Kan B Infect Immun; 2003 Oct; 71(10):5498-504. PubMed ID: 14500467 [TBL] [Abstract][Full Text] [Related]
34. Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR in healthy adults age 18-45. McCarty JM; Lock MD; Hunt KM; Simon JK; Gurwith M Vaccine; 2018 Feb; 36(6):833-840. PubMed ID: 29317118 [TBL] [Abstract][Full Text] [Related]
35. Dissecting serotype-specific contributions to live oral cholera vaccine efficacy. Sit B; Fakoya B; Zhang T; Billings G; Waldor MK Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33558237 [TBL] [Abstract][Full Text] [Related]
36. [Tolerance and immunogenicity of an oral dose of CVD 103-HgR, a live attenuated Vibrio cholerae 01 strain: a double-blind study of Chilean adults]. Lagos R; Avendaño A; Horwitz I; Prado V; Ferreccio C; Sotomayor V; Losonsky G; Wasserman SS; Cryz S; Kaper JB Rev Med Chil; 1993 Aug; 121(8):857-63. PubMed ID: 8296092 [TBL] [Abstract][Full Text] [Related]
37. Transient Intestinal Colonization by a Live-Attenuated Oral Cholera Vaccine Induces Protective Immune Responses in Streptomycin-Treated Mice. Fakoya B; Sit B; Waldor MK J Bacteriol; 2020 Nov; 202(24):. PubMed ID: 32540930 [TBL] [Abstract][Full Text] [Related]
38. Oral immunization with a probiotic cholera vaccine induces broad protective immunity against Vibrio cholerae colonization and disease in mice. Sit B; Zhang T; Fakoya B; Akter A; Biswas R; Ryan ET; Waldor MK PLoS Negl Trop Dis; 2019 May; 13(5):e0007417. PubMed ID: 31150386 [TBL] [Abstract][Full Text] [Related]
39. [The current status of research on a cholera vaccine]. Fournier JM Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):412-5. PubMed ID: 10078377 [TBL] [Abstract][Full Text] [Related]
40. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens. Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]